• 340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
• Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
• Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2015 (HR 1078); FDA, NIH, and BARDA/CDC appropriations.
• STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)

Duration: April 1, 2011 to June 30, 2015

General Issues: Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark, Medical/Disease Research/Clinical Labs, Manufacturing, Taxation/Internal Revenue Code

Spending: about $3,900,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Labor - Dept of (DOL),